BioSpace News Archive

Nucleix Announces its Bladder EpiCheck™ Availability on the QIAGEN Rotor-Gene Q Platform

Significantly extending the commercial potential reach for Bladder EpiCheck

March 14, 2018
·
1 min read
Business

TARIS® Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy

Collaboration with Uppsala Clinical Research Center and Professor Per-Uno Malmström

March 14, 2018
·
3 min read
Policy

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies

Patents strengthen Company’s intellectual property portfolio for its lead product candidate ASN100 which is designed to uniquely address Staphylococcus aureus infections

March 14, 2018
·
3 min read
Biotech Bay

Arcadia Biosciences Achieves Key Resistant Starch Wheat Technology Milestones, Prepares for Commercial Launch

-- New Non-GM Wheat Varieties Naturally High in Amylose and Fiber Create Unique Value Opportunities for Consumer Branded Products and Tangible Health Benefits for Consumers --

March 14, 2018
·
4 min read
Pharm Country

Revealed: Key Trends in the Alternate Site Health Care Industry

Key and emerging trends in the spotlight at the 15th Annual MHA Business Summit

March 14, 2018
·
3 min read
Pharm Country

InventHelp Inventor Develops Improved Mobility Cane for the Visually Impaired (SDB-1170)

The cane keeps the user from bumping into objects, such as lampposts, trash cans, other people, etc.

March 14, 2018
·
1 min read
Business

Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

Ra Pharmaceuticals, Inc. announced financial results for the fourth quarter and year ended December 31, 2017 and provided an update on recent corporate and clinical developments.

March 14, 2018
·
8 min read
Zymeworks Advances Clinical Candidate Incorporating Technology from Kairos Acquisition

Zymeworks Inc. announced that ZW49 is the first product candidate selected for clinical development utilizing the ZymeLink™ antibody-drug conjugate (ADC) platform, acquired as part of the Company’s 2016 acquisition of Kairos Therapeutics.

March 14, 2018
·
3 min read
Business

Zymeworks Reports 2017 Year-End Financial Results

Zymeworks Inc. reported financial results for the year ended December 31, 2017.

March 14, 2018
·
3 min read
Drug Development

Syros to Present New Preclinical Data on SY-1365 in Ovarian Cancer at Upcoming AACR Annual Meeting

Syros Pharmaceuticals announced that the Company and its collaborators from the Dana-Farber Cancer Institute will present new preclinical data on SY-1365.

March 14, 2018
·
2 min read